Back to today’s briefing

Story perspectives

Dr. Richard Pazdur Takes Charge Amid FDA Reforms

11/12/2025

31 7

Summary

Story summary

The U.S. Food and Drug Administration appointed Dr. Richard Pazdur as head of CDER on November 12, 2025.
The appointment follows FDA instability and staff reductions.
Pazdur, a 26-year veteran, aims to implement regulatory reforms and significantly enhance drug development.
He advocates faster authorizations using surrogate endpoints, while remaining skeptical of China trial results amid biotech sector interest.

1 of 1

Story summary

The U.S. Food and Drug Administration appointed Dr. Richard Pazdur as head of CDER on November 12, 2025.
The appointment follows FDA instability and staff reductions.
Pazdur, a 26-year veteran, aims to implement regulatory reforms and significantly enhance drug development.
He advocates faster authorizations using surrogate endpoints, while remaining skeptical of China trial results amid biotech sector interest.